Turning Point Therapeutics, Inc.
MACROCYCLIC KINASE INHIBITORS AND THEIR USE

Last updated:

Abstract:

The present disclosure relates to certain chiral diaryl macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat cancer, pain, neurological diseases, autoimmune diseases, and inflammation.

Status:
Application
Type:

Utility

Filling date:

18 Dec 2018

Issue date:

25 Mar 2021